Contraception: guidelines

CoSRH Guidelines and Statements

• UK Medical Eligibility Criteria for Contraceptive Use (UK MEC) Summary Sheets (2016, amended Sep 2019)^FREE

• CoSRH CEU statement: Benilexa and Levosert 52mg LNG-IUDs: extension of licence for contraception to 8 years August 2024)^FREE
• CEU Statement: Extended use of all 52mg LNG-IUDs for up to Eight Years for Contraception (May 24)^FREE
• Mirena 8 years contraception (Jan 2024)^FREE
• Guidance to Support Clinical Practice During Copper Intrauterine Device Shortages (Sep 23)
• Intrauterine Contraception (Mar 2023; updated July 2023)^FREE
• Progestogen-only Injectable Contraception (Dec 2014, amended Jul 2023)^FREE
• Progestogen-only Implant (Feb 2021, amended Jul 2023)^FREE
• Pain Associated with Insertion of Intrauterine Contraception (June 2021)^FREE

• CEU Statement: Response to New Study by Roland et al (2024). Use of Progestogens and the Risk of Intracranial Meningioma (Mar 24)^FREE
• Drospirenone 4mg Progestogen-only Pill (Slynd®) (Jan 2024)^FREE
• Combined Hormonal Contraception (Jan 2019, amended Oct 2023)^FREE
• Progestogen-only Pills (Aug 2022, amended Jul 2023)^FREE
• Barrier Methods Contraception and STI Prevention (Aug 2012. amended Oct 2015)^FREE
• Fertility Awareness Methods (June 2015)^FREE
• Emergency Contraception (Dec 2017, amended Dec 2023)^FREE

• Supporting Contraceptive Choices for Individuals Who Have or Have Had Breast Cancer (Nov 2023)^FREE
• Contraception after Pregnancy (Jan 2017; updated 2020)^FREE
• Overweight, Obesity and Contraception (April 2019)^FREE
• Contraceptive Choices for Young People (March 2010, amended May 2019)^FREE
• Contraception for Women over 40 (Aug 2017, amended July 2023)^FREE
• Contraceptive Choices for Women with Cardiac Disease (June 2014)^FREE
• Male and Female Sterilisation (Sep 2014)^FREE

• CoSRH Statement: Response to study by Yonis et al. Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study (Feb 2025)^FREE 
• CoSRH Statement and Public Leaflet: Glucagon-like Peptide-1 (GLP-1) Agonists and Oral Contraception (Feb 2025)^FREE
• CoSRH Statement on Ulipristal and Breastfeeding (Jan 25)^FREE
• CoSRH Response to New Study on Use of CHC and POC and Breast Cancer Risk (March 2023)^FREE
• Drug Interactions Between HIV Antiretroviral Therapy (ART) and Contraception (Feb 2023)
• Switching or Starting Methods of Contraception (Nov 2017, amended Apr 2023)
  
• Quick Starting Contraception (April 2017)^FREE
• Problematic Bleeding with Hormonal Contraception (July 2015)^FREE
• Drug Interactions with Hormonal Contraception (updated May 2022)^FREE
• UK Medical Eligibility Criteria for Contraceptive Use (UK MEC) Summary Sheets (2016, amended Sep 2019)^FREE

RCOG Guidelines

• Best Practice in Post-abortion Contraception (Sep 22)
• Choosing Contraception around the Menopause (infographic; links to article)^FREE

NICE Guidelines

• Long-acting Reversible Contraception (CG30, Oct 2005, updated 2019)^FREE